針對肺炎球菌肺炎

針對肺炎球菌肺炎

關於20價

接種疫苗可有助防範肺炎球菌肺炎。1

信心保證
20價肺炎球菌結合型疫苗（PCV20）是輝瑞研發的最新一代疫苗，涵蓋多達 20 種血清型，提供更廣泛的保護。6星期起即可接種，2歲或以上只需一針，為目前市面上唯一無需額外接種其他肺炎疫苗的選擇†。輝瑞擁有超過 20 年肺炎球菌疫苗的研發與接種經驗*，全球累計已有超過 3 億人接種^，安全性與信心備受肯定。 2-4,14-15
PCV20 傳承時間線

不同國家引起兒童入侵性肺炎球菌疾病的血清型分佈 （2014-2022）5-10

Worldwide paed IPD case

上述數據來源涵蓋不同年份及年齡層，詳情請參閱原始資料網站。

不同國家引起成人入侵性肺炎球菌疾病的血清型分佈 （2014-2019）5,6,10-13

Worldwide adult IPD case

上述數據來源涵蓋不同年份及年齡層，詳情請參閱原始資料網站。

向醫生查詢

向醫生查詢

肺炎球菌疫苗均乃醫生處方藥物。藥物的成效和副作用可能因使用者的身體狀況及個別症狀而有所不同，詳情請向醫生或藥劑師查詢。

參考資料

  1. National Foundation for Infectious Diseases. What is pneumococcal disease? Available at: www.nfid.org/infectious-disease/pneumococcal/. Accessed Oct 2025.
  2. Ho PL, et al. Diagn Microbiol Infect Dis 2011;71:327-334.
  3. Drug Office. Search drugs database. Available at: www.drugoffice.gov.hk/eps/drug/productDetail/en/pharmaceutical_trade/138577. Accessed Oct 2025.
  4. Chapman R, et al. Vaccine 2020;38:7138-7145.
  5. CHP. Report on IPD. Available at: https://www.chp.gov.hk/en/resources/29/636.html Accessed Oct 2025.
  6. Ladhani SN, et al. Lancet Infect Dis 2018;18:441-451.
  7. Simell B, et al. Clin Infect Dis 2022;76:e1062-e1070.
  8. Dipartimento Malattie Infettive, Istituto Superiore di Sanità. Sorveglianza delle malattie batteriche invasive in Italia, Rapporto Consolidato 2018. Available at: www.iss.it/documents/20126/0/Rapporto+consolidato+MIB+2019.pdf/1faeb457-9859-4809-bf8a-4eaf405937c1?t=1621576238. Accessed Dec 2024.
  9. Kim SH, et al. Ann Lab Med 2023;43:45-48.
  10. Ubukata K, et al. Emerg Infect Dis 2018;24:2010-2020.
  11. Silva-Costa C, et al. Microorganisms 2021;9:1016.
  12. Dipartimento Malattie Infettive, Istituto Superiore di Sanità. Sorveglianza delle malattie batteriche invasive in Italia, Rapporto Consolidato 2019. Available at: www.iss.it/documents/20126/0/Rapporto+consolidato+MIB+2019.pdf/1faeb457-9859-f800-b9aa-bf8aea405093?t=1612517562338. Accessed Oct 2025.
  13. Kim GR, et al. Serotype Distribution and Antimicrobial Resistance of Streptococcus pneumoniae Causing Invasive Pneumococcal Disease in Korea Between 2017 and 2019 After Introduction of the 13-Valent Pneumococcal Conjugate Vaccine. Ann Lab Med 2023;43:45-54. https://doi.org/10.3343/alm.2023.43.1.45 Accessed Oct 2025
  14. CHP. Frequently Asked Questions. Available at: https://www.chp.gov.hk/en/features/100770.html Accessed Oct 2025
  15. CDC. Pneumococcal Vaccine Timing for Adults. Available at: https://www.cdc.gov/pneumococcal/downloads/Vaccine-Timing-Adults-JobAid.pdf Accessed Oct 2025
style
Section-refer